Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression.

The American journal of psychiatry - 1 Oct 2007

Laje Gonzalo, Paddock Silvia, Manji Husseini, Rush A John, Wilson Alexander F, Charney Dennis, McMahon Francis J

Abstract excerpt

OBJECTIVE: Suicidal ideation is an uncommon symptom than can emerge during antidepressant treatment. The biological basis of treatment-emergent suicidal ideation is unknown. Genetic markers may shed light on the causes of treatment-emergent suicidal ideation and help identify individuals at high...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ambulatory Care
Share to Citalopram
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Receptors, Glutamate

Share to Selective Serotonin Reuptake Inhibitors

Share to Suicide

Share to United States

Source

Identifiers

PMID: 17898344
DOI: 10.1176/appi.ajp.2007.06122018

Genes

GRIA3
GRIK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17898344-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression.PMID 17898344Read ↗

Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.Semantic proximity Read ↗

Suicidal ideation during antidepressant treatment: do genetic predictors exist?Semantic proximity Read ↗

Genome-wide association study of antidepressant treatment-emergent suicidal ideation.Semantic proximity Read ↗

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.Semantic proximity Read ↗

Pharmacogenetics studies in STAR*D: strengths, limitations, and results.Semantic proximity Read ↗

Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.Semantic proximity Read ↗

Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.Semantic proximity Read ↗

Distinguishing clinical and genetic risk factors for suicidal ideation and behavior in a diverse hospital populationSemantic proximity Read ↗

Heterogeneous effects of antidepressants on suicidal ideation: role of polygenic scoresSemantic proximity Read ↗

Polygenic risk scores for psychiatric, inflammatory, and cardio-metabolic traits and diseases highlight possible genetic overlaps with suicide attempt and treatment-emergent suicidal ideationSemantic proximity Read ↗

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.Semantic proximity Read ↗

Multivariate genome-wide association study of suicidal behaviors in >1.7 million individuals of diverse population descentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.